This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Invention for Innovation Programme - Connect Committee



The funding committees for the NIHR Invention for Innovation (i4i) Programme are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members. i4i has four committees: two for Product Development Awards (committee A and committee B), one for Challenge Awards, and one for Connect.

Committee members - Connect

 Name Position Organisation Expertise
Professor Paul Sibbons (Chair) Consultant Independent pre-clinical Consultant Paul has extensive experience in pre-clinical surgery, pathology, evaluation and interpretation
Dr Ayokunmi (AJ) Ajetunmobi Venture Development Manager  BioCity Group   Scientist, venture builder, storyteller. Manage venture development activity at BioCity, the UK’s largest bioscience incubator, supporting and investing in disruptive healthcare startups
Dr Peter Bannister VP Clinical Innovation Mirada Medical  Bannister Technologies Peter has helped build multiple high-growth businesses for markets including surgery, clinical trials and diagnostic imaging. He is an Academy of Medical Sciences FLIER trainee 
Dr Anna Barnes Clinical Scientist PETMRI Nuclear Medicine   UCL Hospitals NHS Foundation Trust  Anna joined the Institute of Nuclear Medicine at the beginning of 2012 as principal clinical scientist (Honorary Senior Research Associate) for the Siemens PETMRI scanner located at the UCH Macmillan Cancer Centre. Her work has concentrated on find robust imaging biomarkers for understanding mechanisms of disease or differential diagnosis. She is currently applying these methods to simultaneous PET and MR imaging in Neurology as as exploring the use of normal databases to inform differential diagnosis of dementia and seizure focus in epilepsy
Dr David Brownlee Innovation Advisor  Health and Social Care (HSC) Innovations  Innovation, Intellectual Property, research contracts, commercialisation, medical devices, healthcare, diagnostics, clinical trials, R&D, collaboration, healthcare, patents, licensing, research design
Dr Elin Haf Davies CEO  Aparito  Elin Haf has 20+ years’ experience working clinically (Great Ormond Street Children’s Hospital), academically (University College London) and as a regulatory (European Medicine Agency)
Miss Rosie Forder Public Committee Member   N/A  N/A
Mr Simon Gwynn Managing Director  SG Market Access Ltd  Simon has over 30 years experience of bringing new healthcare technologies into use and ensuring their effective uptake into the NHS to improve patient outcomes
Mr Michael King Medical Technology Analyst  Rx Securities   I monitor the global medical technology industry, analyse the technology, addressable market, strategy and financial potential of individual businesses and assess their value
Professor Nick Lemoine Director Barts Cancer Institute I am the Director of Barts Cancer Institute. My groups' primary research interests are in the genomics and molecular pathology of pancreatic cancer and the development of oncolytic virotherapy
Mr Danny Roberts Public Committee Member N/A N/A
Professor Jacky Smith Professor of Respiratory Medicine The University of Manchester, Director NIHRCRF

I set up and run a multi-disci;inary team of 9 researchers studying mechanisms in and treatments for coughs. I currently co-supervise 4 PhD students. My main interest is the translation of findings in animal models to human physiology and novel treatments. I lead the Rapid Translational Incubator cross cutting theme of the Manchester Biomedical Research Centre and I am the local Director of the Manchester Clinical Research Facility at the Wythenshawe Hospital site and I also set up and run a weekly cough clinic providing a tretiary referral service for which sees approximately 250 new patients and is part of the North West Cough Newtwork

Mr Gary Thorpe Biochemistry Director (WALT) Wolfson Applied Technology Laboratory , University of Birmingham Gary's experience combines academic science with medical diagnostics and technology transfer. Work on chemiluminescent technology resulted in two Queen's Awards for Technological Achievement and Enterprise